Chinese biotech startup Excalipoint banks $69M for next-gen T cell engagers
Shanghai-based Excalipoint Therapeutics has announced the successful closure of a substantial financing round totaling $68.7...
Knowledge and News for the Global Fight Against Cancer.
Shanghai-based Excalipoint Therapeutics has announced the successful closure of a substantial financing round totaling $68.7...
For more than seven decades, the Cancer Research Institute (CRI) has been at the forefront...
A new drug from Pfizer, atirmociclib, is emerging as a critical component of the pharmaceutical...
Bicycle Therapeutics, a clinical-stage biopharmaceutical company leveraging its proprietary "Bicycle" technology to develop a novel...
The tranquil setting of Sailfish Point in Stuart, Florida, once again became a beacon of...
Redwood City, California – March 17, 2026 – In a significant move set to potentially...
The global health community has lauded the remarkable progress in cervical cancer prevention, largely attributable...
Structure Therapeutics, a rapidly emerging biotech firm, has announced compelling Phase 2 trial results for...
CytomX Therapeutics, a biopharmaceutical company focused on developing novel cancer therapies, announced on March 16,...
February marks National Cancer Prevention Month, a dedicated period for the United States to underscore...